Return to Trial Database

HCRN-LUN89-1

Phase II Study of VP-16 Plus Ifosfamide Plus Cisplatin (VIP) as Combination Chemotherapy for Previously Treated Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-LUN89-1 being conducted in.

No data was found